Plunkett Research®, Ltd.

Market Research, Industry Statistics, Trends
and In-depth Analysis of Top Companies

When you want Affordable, Timely Industry Research,
Contacts & Business Development Data

Loading Search
Healthcare

Health Care Industry Market Research




Healthcare Industry:

  • Market Research
  • Industry Trends Analysis
  • Technologies Analysis
  • Business Intelligence
  • Top Companies Database
  • Business Leaders and Corporate Executives
  • Industry Associations Database
  • Export Tools - Build
    Mailing Lists
$299 to $349 gives you 1-year online, plus our printed industry Almanac
Purchase Options
Print - Online - eBook
Get a Quote on a custom market research
project



Secure online ordering, encrypted by Network Solutions. Or, call 713.932.0000
Introduction to the Health Care Industry

¹ Video Tip
For our brief video introduction to the HealthCare industry, see www.plunkettresearch.com/video/healthcare.
Health Expenditures and Services in the U.S.:
Health care costs continue to rise rapidly in the U.S. and throughout the developed world. Total U.S. health care expenditures were estimated to be $2.9 trillion in 2013, and are projected to soar to $3.4 trillion in 2016.
The health care market in the U.S. in 2013 included the major categories of hospital care (about $929.0 billion), physician and clinical services ($588.8 billion), dental services ($116.6 billion) and prescription drugs ($262.3 billion), along with nursing home and home health ($238.6 billion). Registered U.S. hospitals totaled 5,724 properties in 2011, according to an American Hospital Association survey, containing 924,333 beds serving 36.5 million admitted patients during the year.
Medicare, the U.S. federal government’s health care program for Americans 65 years or older, provided coverage to 50.7 million seniors in 2013. National expenditures on Medicare for fiscal 2013 were projected to be $604.2 billion, including premiums paid by beneficiaries. By 2030, the number of people covered by Medicare will balloon to about 78.0 million due to the massive number of Baby Boomers entering retirement age.
Medicaid is the federal government’s health care program for low-income and disabled persons (including children), as well as certain groups of seniors in nursing homes. National expenditures on Medicaid totaled an estimated $436.6 billion in 2013. The majority of that expense is paid for by the federal government. However, the states pick up a significant share of the cost, which is a massive burden on state budgets.
Health spending in the U.S., at about 18.0% of Gross Domestic Product (GDP) in 2013, is projected to grow steadily. Health care spending in America accounts for a larger share of GDP than in any other country by a wide margin. Despite the incredible investment America continues to make in health care, 15.4% of people in the U.S. (48.0 million) lacked health care coverage for the entire year of 2012. For some, insurance was unavailable or unaffordable. In other cases, a lack of insurance was due to a personal decision not to pay for it. A large number of the uninsured are illegal immigrants. A Kaiser Family Foundation study, “Medicaid and the Uninsured,” dated February 2007, estimated that one-fourth of the uninsured were eligible for public programs but were not enrolled. These were largely low-income children, and in some cases their parents.
In March 2010, President Obama signed the Patient Protection and Affordable Care Act ("ACA"), designed to strengthen insurance company regulation and provide medical coverage to more than 30 million currently uninsured Americans. The act calls for sweeping changes. Provisions taking effect within the first six months of signing included coverage for adult children up to age 26 on their parents’ policies; making it unlawful for insurers to place lifetime caps on payouts or deny coverage should a policy holder become ill; and new policies are required to pay the full cost of selected preventive care and exempt that care from deductibles. Effective in 2010, small businesses with fewer than 25 employees and average annual wages of less than $50,000 became eligible for tax credits to cover up to 35% of staff insurance premiums.
Online health care insurance “exchanges” began enabling consumers to shop for health coverage on a state-by-state basis as of October 1, 2013, with the insurance sold to take effect beginning January 1, 2014. However, many aspects of regulations covering the exchanges have been pushed back to 2014 or beyond, as the plan was largely running behind schedule.
Beginning with income earned in 2013, a 3.8% unearned income tax will be levied on individuals earning more than $200,000 per year and families earning more than $250,000 per year to fund the programs in the act. Employers with more than 50 employees that do not offer health benefits will begin paying a $2,000 fine per full time staff member if any of the workers receives a tax credit to buy coverage. This fine was originally scheduled to cover 2014, but in mid-2013 the Obama Administration delayed it until 2015. Businesses with more than 200 employees will be required to enroll all staff automatically in health insurance plans. Also in 2014, the government will begin fining citizens who choose not to carry health insurance. The fine will start at $95 per year or 1% of annual income (whichever is greater), and rise to $695 per year or 2.5% of income by 2016.
 
Health Expenditures Globally and in OECD Developed Nations:
A comprehensive study published by the OECD (Organization for Economic Cooperation & Development) covering more than 30 nations including the majority of the world’s most developed economies (excluding Brazil, Russia, India or China), found stark contrasts between health costs in the United States and those of other nations. In 2011 (the latest complete data available), the average of a list that includes, for example, the UK, France, Germany, Mexico, Canada, South Korea, Japan, Australia and the U.S., spent 9.3% of GDP on health care. The highest figures were in America at 17.7% of GDP, The Netherlands at 11.9%, France at 11.6%, Germany at 11.3%, Denmark at 10.9% Canada at 11.2% and Switzerland at 11.0%.
Total health care expenditures around the world are difficult to determine, but $6.15 trillion would be a fair estimate for 2013. That would place health care at about 8.2% of global GDP, with expenditures per capita about $866. This $6.15 trillion breaks down to approximately $2.9 trillion in the U.S., $2.6 trillion in non-U.S. OECD nations and $0.65 trillion elsewhere around the world. Outside the U.S. and the rest of the OECD, that would allow roughly $90 per capita per year. Clearly, there is vast disparity in the availability and cost of care among nations, as there is with personal income and GDP. Health care spending per capita in the U.S. was equal to about $9,216 in 2013, while spending in the world’s remotest villages was next to nothing. The trend over the near future is for the modest amount now spent on health care in emerging nations to rise dramatically, while OECD nations like America struggle to contain their own mountainous costs. Globally, the total prescription drug market was over $1 trillion in 2013.
 
Health Care Costs in the U.S.
Particularly in the U.S., continuous increases in the cost of health care, growing at rates far exceeding the rate of inflation in general, are hammering health consumers and payors of all types. Insurance providers continue to struggle to contain costs. Meanwhile, employers are hit hard by vast increases in the cost of providing coverage to employees and retirees.  
The Kaiser Family Foundation estimated that in 2013 an employer’s premium to cover a typical family was $16,351 per year (a 103% increase since 2002), with the typical worker paying 28% ($4,565) of that premium. Employer-provided health care insurance for single coverage cost an average of $9,068, with the employee paying $2,412 of that premium.
Many major employers are utilizing unique new programs in efforts to reduce employee illness, and thereby reduce costs. For example, the use of preventive care programs is growing, as is the use of employee education aimed at better managing the effects of diseases such as diabetes. Some very large employers are even hiring in-house physicians and nurses to provide primary and preventive care in the workplace.
Patients and insurance companies are also dealing with sticker shock over the nation’s prescription drug costs. Other factors edging costs upward include expensive new medical technologies and patients’ demands for greater flexibility in choosing doctors and specialists at their will. At the same time, hospitals and health systems write off massive amounts of revenues to bad debt, which increases costs for bill-paying patients.
In the wake of the tremendous growth of all aspects of the health care industry from the end of World War II onward, efficiency, competition and productivity were, regretfully, largely overlooked. Much of this occurred because employers plus federal and state governments paid such a large portion of the health care bill, to the extent that patients were generally not sensitive to health care costs.
A study released by the Milken Institute in 2007 found that during the year 2003 (the year on which the study focused), 109 million Americans suffered from one or more of the most common, chronic diseases, including cancer, diabetes, heart disease, pulmonary conditions, mental disorders, stroke or hypertension. This means that more than one-third of all Americans had these conditions to one degree or another. The study estimated one year’s cost of treatment of these conditions at $277 billion, but estimated lost economic productivity to be vastly higher at $1 trillion. In other words, lost work and lost output due to these illnesses reduced the nation’s GDP by about 10%. These burdens could be vastly reduced through better consumer health practices and better preventive medicine. For example, obesity, lack of exercise and cigarette smoking are immense contributors to these diseases. The Centers for Disease Control and Prevention reported that medical costs for obesity-related diseases rose as high as $147 billion in 2008, compared to $74 billion in 1998.
 
The American health care industry faces more challenges than ever, due to a number of significant factors:
·         The net effect of the massive health care act passed in 2010 remains to be seen. However, one of the most dramatic results to date is consolidation within the hospital industry, with mergers creating massive organizations that in many cases have dominant market share in major cities. A similar effect has been a flood of physicians leaving private practice or small clinics to join giant physician practice groups or join the staff of hospitals. Physicians are concerned about their ability to meet increased regulatory scrutiny, successfully deploy electronic health records and earn the incomes that they desire. Many older physicians state that they will simply retire earlier than they had planned.
·         The U.S. population is aging rapidly. At the same time, the life expectancy of seniors is extending. Senior citizens will place a significant strain on the health care system in coming years. America’s 75 million surviving Baby Boomers began turning 65 in 2011.
·         The future obligations of Medicare and Medicaid are enough to cause vast problems for federal and state budgets for decades to come. The number of seniors covered by Medicare will continue to grow at an exceedingly high rate, from 47.4 million people in 2010 to 78.0 million in 2030.
·         Likewise, costs for Medicaid, which is administered at the state level, have grown so rapidly that they are competing fiercely for budget dollars that might otherwise go to education and other vital state-provided services.
·         The pharmaceuticals industry faces continued financial challenges. Pharmaceutical costs have created a large backlash among health consumers and payors. Patents for money-making, blockbuster drugs are expiring at a rapid rate, increasing competition from makers of generic drugs. As a result pharmaceutical makers are slashing staff and reducing research and development while acquiring small, innovative biotech companies.
·         We are now in what will long be remembered as the beginning of the Biotech Era. Breakthroughs in research for targeted drug therapies are occurring at a rapid pace, and highly advanced, genetically-engineered drugs are entering the market.
·         Due to rising costs, employers large and small are straining under the financial burden of health care coverage expenses for current employees and retirees.
·         Physicians, hospitals, medical device makers and pharmaceutical manufacturers face daunting pressure from litigation and claims regarding malpractice. Lawsuit reform legislation has recently been enacted in many states with very promising results.
·         Few Americans focus on leading healthy lifestyles that would prevent disease and cut both the amount and the cost of medical care.  Obesity-related illnesses are adding an immense amount to the nation’s health care costs. Large numbers of people smoke cigarettes and/or do not exercise regularly.
·         The three biggest causes of death in the U.S. are heart disease, cancer and stroke. Nearly one-fourth of America’s annual health expenditures go for treatment of these three killers.
·         While only a relatively modest amount of money is spent on preventive medicine and health education, about 70% of health care funds are spent on chronic disease.
Source: Plunkett Research, Ltd.

View More



Video Introduction to Health Care Industry
Complete list of market research data provided by Plunkett Research, Ltd. for the Health Care Industry
  • Continued Rise in Health Care Costs
  • Employers Push Health Care Costs onto Employees
  • Medicare and Medicaid Spending Continue to Surge/Oldest Baby Boomers Hit 65+ Years of Age
  • U.S. Health Care Reform Act of 2010 Set to Bring Big Changes
  • Accountable Care Organizations Grow Quickly/Massive Merges in Hospital Firms
  • Concierge Care/Direct Primary Care Are on the Rise
  • Insurance Companies Change Strategies Due to Health Care Reform Act
  • Vast Number of Uninsured and Underinsured Americans
  • Few New Blockbusters: Major Drug Patents Expire While Generic Sales Growth Continues/Drug Prices Soar
  • Biotech and Orphan Drugs Create New Revenues for Drug Firms
  • Quality of Care and Health Care Outcomes Data Become Available Online
  • Malpractice Suits Are Blamed for Rising Health Care Costs/Tort Reform Is Capping Awards for Damages
  • Obesity Sparks Government Action/Snack Foods Get Healthier
  • Health Care Goes Offshore, Medical Tourism and Clinical Trials Thrive in China, India and Elsewhere
  • Clinics Open in Retail Store Settings and Employer Sites
  • Health Care Industry Grows Rapidly in China, India and Mexico
  • Health Care Technology Introduction
  • Health Information Research Remains a Leading Use of the Internet
  • RFID Helps Manage Hospital and Pharmacy Inventories
  • Electronic Health Records (EHR) Digitize Patient Records at an Accelerating Pace
  • The Personal Health Internet: Remote Patient Monitoring Advances Through Wireless Systems
  • Stem Cells—Multiple Sources Stem from New Technologies
  • Government Support for Stem Cell Research Evolves
  • Stem Cells—Therapeutic Cloning Techniques Advance
  • Stem Cells—A New Era of Tissue Replacement Takes Shape
  • Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
  • Drug Delivery Systems Evolve to Meet the Needs of Biotech Drugs
  • Advances for Cancer Patients in Chemotherapy and Radiation, Including Proton Beams and IMRT
  • Better Imaging, including MRI, PET and 320-Slice CT, Creates Advances in Detection
  • Nanotechnology Makes Breakthroughs in Health Care
  • Complete list of statistics data provided by Plunkett Research, Ltd. for the Health Care Industry
  • U.S. Health Care Industry Overview

  • Global Health Statistics
  • Affordable Care Act Overview
  • Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1975-2012
  • Employment in the Health Care Industry, U.S.: 2007-2012
  • Employment & Earnings in Health Care Practitioner & Technical Occupations, U.S.: May 2012
  • Employment & Earnings in Health Care Support Occupations, U.S.: May 2012
  • Federal R&D & R&D Plant Funding for National Institutes of Health, U.S.: Fiscal Years 2012-2014
  • The U.S. Drug Discovery & Approval Process
  • U.S. FDA New Drug and Biologic Approvals, 2013
  • The Nation's Health Dollar: 2013 Where It Came From (Estimated)
  • The Nation's Health Dollar: 2013 Where It Went (Estimated)
  • National Health Expenditures & Annual Percent Change: 2006-2022
  • National Health Expenditures by Type of Expenditure with Affordable Care Act Impacts, U.S.: Selected Calendar Years, 2006-2022
  • National Health Expenditures by Type of Expenditure without Affordable Care Act Impacts, U.S.: Selected Calendar Years, 2006-2022
  • Hospital Care Expenditures & Annual Percent Change, U.S.: 2006-2022
  • Hospital Care Expenditures, Percent Distribution & Per Capita Amount, U.S.: 2006-2022
  • Nursing Home Care Expenditures & Annual Percent Change, U.S.: 2006-2022
  • Nursing Home Care Expenditures, Percent Distribution & Per Capita Amount: 2006-2022
  • Home Health Care Expenditures & Annual Percent Change, U.S.: 2006-2022
  • Home Health Care Expenditures, Percent Distribution & Per Capita Amount, U.S.: 2006-2022
  • Prescription Drug Expenditures, U.S.: 1970-2022
  • U.S. Prescription Drug Expenditures & Annual Percent Change: 2006-2022
  • U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Precent Distribution: 2006-2022
  • Medicare Enrollment, 1970-2085
  • Medicare Cost & Non-Interest Income by Source as a Percent of GDP, 1970-2087
  • Medicare Beneficiaries with Prescription Drug Coverage, Summary Report: July 2013
  • Medicaid Enrollment & Expenditures for Medical Assistance Payments & Administration: Selected Years, 1966-2021
  • Medicaid Enrollment & Expenditures, by Enrollment Group: Fiscal Year 2011
  • Number & Percent of Persons of All Ages with and without Health Insurance Coverage, U.S.: 1999-2012
  • Number & Percent of Persons of All Ages without Health Insurance Coverage, by Race/Ethnicity, U.S.: 2002-2012
  • Number & Percent of Persons without Health Insurance Coverage, by Age Group, U.S.:1999-2012
  • Number & Percent of Persons without Health Insurance Coverage, by Age Group & Sex, U.S.: 2012
  • Medical Care Benefits in the U.S.: Access, Participation and Take-Up Rates, March 2013
  • Employers' Costs for Health Insurance, Amount and Percent of Total Compensation, U.S.: Selected Years 2005-2013
  • Life Expectancy at Age 65, U.S.
  • Current Cigarette Smoking by Persons 18 Years of Age & Over, U.S.: 1997-2012
  • Current Cigarette Smoking, by Age Group and Sex, U.S.: 2012
  • Overweight & Obesity Among Adults, by Sex, Race & Hispanic Origin, U.S.: Selected Years, 1960-2010
  • Prevalence of Obesity Among Adults, by Age Group & Sex, U.S.: 2012
  • Table of Contents for Plunkett's Health Care Industry Almanac  
    See Full Table of Contents

    how to use this book 3
    chapter 1: major trends and technologies affecting the health care industry 7
    1) introduction to the health care industry 7
    2) continued rise in health care costs 10
    Profiles of Leading Health Care Companies are provided, including Public, Private, U.S., and non-U.S. Firms.  
    See Full List of Companies

    • 3M Company
    • 3SBio Inc
    • Abbott Laboratories
    • Abbott Medical Optics Inc
    • Abiomed Inc
    • Acadia Healthcare Company Inc
    • Accredo Health Group Inc
    • Accuray Inc
    • Actavis plc
    • Actelion Ltd
  • Actelion Ltd
  • Addus Homecare Corp
  • Advanced Bionics LLC
  • Adventist Health System
  • Advocate Health Care
  • AEterna Zentaris Inc
  • Aetna Inc
  • AFLAC Inc
  • Agfa-Gevaert NV
  • Air Methods Corp
  • Key Health Care Industry Topics
  • Managed Care
  • Health Services
  • Health Care Products
  • Diagnostics
  • Health Technologies and Systems
  • Pharmaceuticals, Drugs, Medicines
  • Hospitals, Clinics
  • Long Term Care
  • Outpatient Surgery
  • Supplies
  • Imaging and Payors
  • Medicare, Medicaid, HMOs, PPOs
  • Benefits
  • Insurance
  • Employers and Health Savings Accounts
  • Profiles of Leading Health Industry Firms
  • Executive Mailing Lists